Immunohistochemistry of the Androgen Receptor in Human Benign and Malignant Prostate Tissue-Reference-Cited by-同舟云学术

Immunohistochemistry of the Androgen Receptor in Human Benign and Malignant Prostate Tissue

Published:1993-05 Issue:5 Part 1 Volume:149 Page:1015-1019
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Miyamoto Kent K.¹,McSherry Susan A.¹,Dent Georgette A.¹,Sar Madhabananda¹,Wilson Elizabeth M.¹,French Frank S.¹,Sharief Yousuf¹,Mohler James L.¹

Affiliation:

1. From the Departments of Surgery (Division of Urology), Pathology (Division of Surgical Pathology), Cell Biology and Anatomy, and Pediatrics (Division of Pediatric Endocrinology), and Lineberger Cancer Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. Studies on prostatic cancer: the effect of castration, of estrogen and of androgen injection on serum phosphatases on metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941

2. Orchiectomy for advanced prostatic carcinoma;Blackard;A reevaluation. Urology,1973

3. Steroid receptors in breast cancer;De Sombre;New Engl. J. Med.,1979

4. Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer;Byar;Eur. J. Cancer,1979

5. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients;Alanko;Cancer,1985

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma;Scientific Reports;2024-05-05

2. Scoring Systems for Immunohistochemistry in Urothelial Carcinoma;Urothelial Carcinoma;2023

3. Reciprocal regulation of CIP2A and AR expression in prostate cancer cells;Discover Oncology;2022-09-13

4. Differences in SUV39H1 and androgen receptor distribution in adenomyomatous hyperplasia and prostatic adenocarcinoma;Nigerian Journal of Clinical Practice;2022

5. Understanding and targeting prostate cancer cell heterogeneity and plasticity;Seminars in Cancer Biology;2021-11